Učitavanje...
Treg cells, cancer vaccines: timing is everything
In the current issue of Blood, Litzinger and colleagues demonstrate the critical role of proper timing of the denileukin diftitox (ONTAK) treatment for its ability to boost the immunologic activity of cancer vaccines.
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2007
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2200914/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-102921 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|